Cost effectiveness of nifedipine compared with atosiban in the treatment of threatened preterm birth (APOSTEL III trial)

MLA

Nijman, Tobias A. J., et al. Cost Effectiveness of Nifedipine Compared with Atosiban in the Treatment of Threatened Preterm Birth (APOSTEL III Trial). 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1303694244&authtype=sso&custid=ns315887.

APA

Nijman, T. A. J., van Baaren, G. J., van Vliet, E. O. G., Kok, M., Gyselaers, W., Porath, M. M., Woiski, M., de Boer, M. A., Bloemenkamp, K. W. M., Sueters, M., Franx, A., Mol, B. W. J., & Oudijk, M. A. (2019). Cost effectiveness of nifedipine compared with atosiban in the treatment of threatened preterm birth (APOSTEL III trial).

Chicago

Nijman, Tobias A J, Gert Jan van Baaren, Elvira O G van Vliet, Marjolein Kok, Wilfried Gyselaers, Martina M Porath, Mallory Woiski, et al. 2019. “Cost Effectiveness of Nifedipine Compared with Atosiban in the Treatment of Threatened Preterm Birth (APOSTEL III Trial).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1303694244&authtype=sso&custid=ns315887.